UCSF Addiction Conference 2025

April 17 – 18, 2025
The 5th Annual UCSF Addiction CME Conference aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care. This is a Virtual Conference.
Target Audience
Physicians
Nurse practitioners and Physician Associates (PAs)
Topics Covered

Keynote address from a person with lived experience of Substance Use Disorder (SUD)
SUD as a brain disease, stigma
Opioid Use Disorder, including starting buprenorphine and methadone
Alcohol use disorder
Benzodiazepine use disorder and withdrawal management
Stimulant use disorder
Pregnancy and SUDs
Pain and SUDs
Hospital based care for patients with SUDs
Communication and documentation in caring for patients with SUDs

Objectives
Attendees completing this course will be able to:

Apply new knowledge in practice to more often recognize signs of substance use disorders (SUDs)
Implement screening in practice to confirm SU
Consider a broader set and combination of evidence-based treatments for opioid, alcohol, and stimulant use disorders in management of SU

 
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
10_Dianna Coffa – Communication with Patients.pdf
11_Tauheed Zaman – Benzodiazepine.pdf
12_Alex Logan – Hospital Based Care.pdf
13_Hannah Snyder – Telehealth and Patient Centered Documentation.pdf
14 _Case 2- AUD, Stim UD, Benzo UD_FACILITATOR (1).docx
14 _Case 2- AUD, Stim UD, Benzo UD_PARTICIPANT.docx
15_Jesse Ristau – Rapid Review of Case 2.pdf
16_Mishka Terplan – Pregnancy and SUD.pdf
17_Elizabeth Abbs – Controlled Medication Management.pdf
2_Johanna Sluser – Stigma and Clinical Diagnosis of SUD.pdf
3_VERSION 2_Khaled Moussawi_SUD as a Brain Disease.pdf
4 _Andy Tompkins – OUD Diagnosis and Methadone Induction.pdf
5_Christy Soran – Complex Buprenorphine Inductions.pdf
6_Case 1- OUD_FACILITATOR (1).docx
6_Case 1- OUD_PARTICIPANT.docx
7_ Jesse Ristau – Rapid Review of Case 1.pdf
8_ Ayesha Appa – Stimulant Use Disorder Treatment.pdf
9_ Triveni Defries – Alcohol Use Disorder.pdf
April 17 AM.mp4
April 17 PM.mp4
April 18 AM.mp4
April 18 PM.mp4
Syllabus Introduction_MDM25P05.pdf
 
* Detail:

Day 1: April 17, 2025

8:00am – 8:15am
Welcome from the Conference Co-Chairs: Jesse Ristau*, MD and Alex Logan*, MD

8:15am -8:55am
Jose P, Drug and Alcohol Counselor
Drug Treatment Program
Keynote Address

8:55am – 9:25am
Johanna Sluser*, FNP-C, CARN-AP
Hospital medicine, Psychiatry
Stigma and clinical diagnosis of SUD

9:25am -9:55am
Khaled Moussawi, MD, PhD – University of California San Francisco
Neurology
SUD as a brain disease

Break – 15 mins 

10:10am -11:10am
Andy Tompkins*, MD
Psychiatry, OTP
OUD diagnosis and methadone induction

11:10am -12:10pm
Christy Soran*, MD, MPH
Primary Care, OBIC
Complex Buprenorphine Inductions

Lunch Break – 12:10pm – 1:40pm 

1:40pm -2:20pm
Small Groups
Case 1: OUD diagnosis and treatment

2:20pm -2:35pm
Jesse Ristau*, MD
Primary Care, Inpatient Consult
Rapid review of Case 1 Clinical Pearls

Break – 15 mins 

2:50pm -3:50pm
Ayesha Appa*, MD
Internal Medicine
Stimulants, drug involved deaths

3:50pm -4:50pm
Triveni Defries*, MD
Internal Medicine
Alcohol Use Disorder: Diagnosis and Treatment

4:50pm -5:00pm
Closing

Day 2: April 18, 2025

8:00am -8:15am
Introductions: Jesse Ristau*, MD and Alex Logan*, MD

8:15am -8:55am
Dianna Coffa*, MD
Family & Community Medicine, ZSFG
Communication with patients who use substances

8:55am -9:55am
Tauheed Zaman*, MD
Psychiatry, SFVA
Benzodiazepine Use disorder and detoxification

Break – 15 mins 

10:10am -11:10am
Alex Logan*, MD
Hospital Medicine
Hospital based care for patients with SUD including Opioid Withdrawal Management

11:10am-12:10pm
Hannah Snyder*, MD
Family & Community Medicine, ZSFG
Telehealth and Patient Centered Documentation

Lunch Break – 12:10pm – 1:40pm 

1:40pm -2:20pm
Small Groups
Case 2: Complex care inpt, outpt, multiple substances, utox (includes 5min of transition time)

2:20pm -2:35pm
Jessica Ristau*, MD
Primary care and Inpatient consult
Rapid Review of Case 2 Clinical Pearls

Break – 15 mins 

2:50pm -3:50pm
Mishka Terplan*, MD
OB/GYN
Pregnancy and SUD

3:50pm -4:50pm
Elizabeth Abbs*, MD
Internal Medicine
Controlled medication management and SUD

4:50pm -5:00pm
Closing